Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2017 Apr 1;21(4):412–419. doi: 10.5588/ijtld.16.0428

Table 3.

Test performance for the diagnosis of active TB

TST
n (%)* (95% CI)
Standard ELISpot
n (%)* (95% CI)
Enhanced ELISpot
n (%)* (95% CI)
Sensitivity
 Definite/probable TB 9/45 (20) (10–35)   18/43 (42) (27–58) 20/43 (45) (31–62)
 Definite TB§ 6/16 (38) (15–65)   8/15 (53) (27–79) 10/15 (67) (38–88)
Specificity
 No TB 124/127 (98) (93–100) 105/119 (88) (81–94) 98/119 (82) (74–89)
Predictive values#
 PPV 9/12 (75) (43–95)   18/32 (56) (38–74) 20/41 (49) (33–65)
 NPV 124/160 (78) (70–84)   105/130 (81) (73–87) 98/121 (81) (73–88)
*

All percentages rounded to the nearest whole number.

ELISpot was invalid in 7% (3/46) of children with TB and 6% (8/127) of those with no TB.

Proportion of children testing positive for a given test among those with culture-confirmed or clinically diagnosed TB.

§

Proportion of children testing positive for a given test among those with culture-confirmed TB only.

Proportion of children testing negative for a given test among those in whom TB was excluded.

#

Predictive values for definite/probable TB at baseline evaluation.

TB = tuberculosis; TST = tuberculin skin test; CI = confidence interval; ELISpot = enzyme linked immunospot based assay; PPV = positive predictive value; NPV = negative predictive value.